Voyager Therapeutics shares jump after $1.2 billion deal with Novartis

Voyager Therapeutics said on Tuesday Novartis would pay $100 million upfront as part of a licensing deal to develop gene therapy candidates. Voyager, whose shares jumped 35% in premarket trading, would provide Novartis a target-exclusive license to access its RNA-based screening platform and…#voyagertherapeutics #voyager #novartis #rna #huntington
Source: Reuters: Health - Category: Consumer Health News Source Type: news